Clinician’s Brief spotlights regenerative therapies in general practice

Clinician’s Brief has published a sponsored podcast episode, “Incorporating Regenerative Therapies Into Practice With Dr. Malhotra,” featuring Rohit Malhotra, DVM, MBA, in conversation with host Beth Molleson, DVM. The May 2026 episode frames regenerative medicine as something that’s moving beyond referral and specialty settings, with a focus on what these therapies include, which patients may be appropriate candidates, and what it takes for general practice teams to start offering them. The episode is sponsored by Hilltop Bio, a company that says its regenerative biologic products are used in more than 1,000 clinics and that it is running four studies intended to generate data relevant to FDA standards. (cliniciansbrief.com)

Why it matters: For veterinary professionals, the significance isn’t just the educational content. It’s that regenerative medicine is increasingly being positioned as a practical service line for general practice, especially around musculoskeletal care and recovery support. At the same time, the regulatory and evidence base is still evolving. FDA says animal cell- and tissue-based products can fall under new animal drug oversight, and the Merck Veterinary Manual notes there are currently no FDA-approved cell-based regenerative treatments for veterinary use in the U.S., with ongoing variation in protocols and reported efficacy. (fda.gov)

What to watch: Expect more attention on how clinics evaluate candidate cases, product claims, training needs, and regulatory status as regenerative therapies move further into everyday practice. (cliniciansbrief.com)